MacroGenics, Inc. (FRA:M55)

MacroGenics Statistics

Total Valuation

MacroGenics has a market cap or net worth of EUR 99.52 million. The enterprise value is 5.48 million.

Market Cap	99.52M
Enterprise Value	5.48M

Important Dates

The next estimated earnings date is Friday, March 6, 2026.

Earnings Date	Mar 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	63.26M
Shares Outstanding	n/a
Shares Change (YoY)	+0.95%
Shares Change (QoQ)	+0.23%
Owned by Insiders (%)	2.38%
Owned by Institutions (%)	43.20%
Float	52.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.91
PB Ratio	1.74
P/TBV Ratio	1.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.08
EV / Sales	0.05
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.04

Financial Position

The company has a current ratio of 5.22, with a Debt / Equity ratio of 0.55.

Current Ratio	5.22
Quick Ratio	4.85
Debt / Equity	0.55
Debt / EBITDA	n/a
Debt / FCF	-0.22
Interest Coverage	-26.97

Financial Efficiency

Return on equity (ROE) is -81.13% and return on invested capital (ROIC) is -54.99%.

Return on Equity (ROE)	-81.13%
Return on Assets (ROA)	-26.52%
Return on Invested Capital (ROIC)	-54.99%
Return on Capital Employed (ROCE)	-50.19%
Revenue Per Employee	318,990
Profits Per Employee	-189,670
Employee Count	341
Asset Turnover	0.48
Inventory Turnover	30.59

Taxes

In the past 12 months, MacroGenics has paid 894,063 in taxes.

Income Tax	894,063
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -53.49% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-53.49%
50-Day Moving Average	1.30
200-Day Moving Average	1.33
Relative Strength Index (RSI)	66.32
Average Volume (20 Days)	608

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.91

Income Statement

In the last 12 months, MacroGenics had revenue of EUR 108.78 million and -64.68 million in losses. Loss per share was -1.03.

Revenue	108.78M
Gross Profit	-47.60M
Operating Income	-96.81M
Pretax Income	-63.78M
Net Income	-64.68M
EBITDA	-90.40M
EBIT	-96.81M
Loss Per Share	-1.03

Balance Sheet

The company has 124.77 million in cash and 31.54 million in debt, with a net cash position of 93.23 million.

Cash & Cash Equivalents	124.77M
Total Debt	31.54M
Net Cash	93.23M
Net Cash Per Share	n/a
Equity (Book Value)	57.10M
Book Value Per Share	0.90
Working Capital	159.91M

Cash Flow

In the last 12 months, operating cash flow was -138.47 million and capital expenditures -1.95 million, giving a free cash flow of -140.42 million.

Operating Cash Flow	-138.47M
Capital Expenditures	-1.95M
Free Cash Flow	-140.42M
FCF Per Share	n/a

Margins

Gross margin is -43.76%, with operating and profit margins of -89.00% and -59.46%.

Gross Margin	-43.76%
Operating Margin	-89.00%
Pretax Margin	-58.64%
Profit Margin	-59.46%
EBITDA Margin	-83.10%
EBIT Margin	-89.00%
FCF Margin	n/a

Dividends & Yields

MacroGenics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.95%
Shareholder Yield	-0.95%
Earnings Yield	-64.99%
FCF Yield	-141.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MacroGenics has an Altman Z-Score of -6.01 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.01
Piotroski F-Score	2